Lanalyn Thangkhiew, Benjamin Nongrum, Wanslempor Kshiar, Julie Birdie Wahlang, Arky Jane Langstieh, Melambha Surong


Glaucoma is the cause for 8.0% cases of preventable blindness cases as per lancet report of 2017. The disease is divided primarily into primary and secondary types, of which the commonest being primary with no exact etiology. Despite availability of more efficacious glaucoma medications with few side effects and findings of clinical trials underscoring the importance of intraocular pressure reduction in POAG patients, many patients with POAG continue to go untreated. Retrospective observational study where consecutive cases of Glaucoma treated at the department of Ophthalmology from January 2014 to December 2018 were analyzed for demographic profiles, diagnosis on type of glaucoma, treatment with Timolol alone or in combination. The most common diagnosis was Primary Open Angle Glaucoma found in 123 patients. Drug treatment with Timolol alone accounted for 59 cases (11.21 %) of the total cases treated for glaucoma. To promote patient adherence, Timolol is also used in combination with other drugs to lower intraocular tension.


Glaucoma, Blindness, Timolol, Efficacy

Full Text:



Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. British journal of ophthalmology. 2006 Mar 1;90(3):262-7.

Langstieh AJ, Nongrum B, Thangkhiew L, Wahlang JB, Brahma DK, Nongkynrih BS, Nongrum PK. A glimpse of glaucoma. Paripex - Indian Journal of Research. 2018 Jul 7; 7:32-33.

Bourne RR, Flaxman SR, Braithwaite T, Cicinelli MV, Das A, Jonas JB, Keeffe J, Kempen JH, Leasher J, Limburg H, Naidoo K. Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis. The Lancet Global Health. 2017 Sep 1;5(9):e888-97..

Diestelhorst M, Larsson LI. A 12 week study comparing the fixed combination of latanoprost and timolol with the concomitant use of the individual components in patients with open angle glaucoma and ocular hypertension. British journal of ophthalmology. 2004 Feb 1;88(2):199-203.

Nathan N, Joos KM. Glaucoma Disparities in the Hispanic Population. In Seminars in ophthalmology 2016 Jul 3 (Vol. 31, No. 4, pp. 394-399). Taylor & Francis.

Higginbotham EJ. Considerations in glaucoma therapy: fixed combinations versus their component medications. Clinical ophthalmology (Auckland, NZ). 2010;4:1.

Varma R, Lee PP, Goldberg I, Kotak S. An assessment of the health and economic burdens of glaucoma. American journal of ophthalmology. 2011 Oct 1;152(4):515-22.


  • There are currently no refbacks.